Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Integra LifeSciences Holdings Corporation - Common Stock
(NQ:
IART
)
11.14
+0.30 (+2.77%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Integra LifeSciences Holdings Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Integra LifeSciences (NASDAQ:IART) Misses Q4 Revenue Estimates
February 25, 2025
Medical device company Integra LifeSciences (NASDAQ:IART) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 11.5% year on year to $442.6 million. Next quarter’s revenue guidance of...
Via
StockStory
Earnings Scheduled For February 25, 2025
↗
February 25, 2025
Via
Benzinga
Integra LifeSciences (IART) Reports Earnings Tomorrow: What To Expect
February 24, 2025
Medical device company Integra LifeSciences (NASDAQ:IART) will be announcing earnings results tomorrow before market hours. Here’s what to look for.
Via
StockStory
Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Paragon 28, Inc. (NYSE: FNA); Integra Lifesciences Holdings Corp. (NASDAQ: IART); Telephone and Data Systems, Inc. (NYSE: TDS); Methode Electronics, Inc. (NYSE: MEI); and
February 10, 2025
From
Grabar Law Office
Via
GlobeNewswire
Unveiling 10 Analyst Insights On Integra Lifesciences
↗
October 01, 2024
Via
Benzinga
Expert Outlook: Integra Lifesciences Through The Eyes Of 8 Analysts
↗
August 22, 2024
Via
Benzinga
Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results
↗
July 30, 2024
Via
Benzinga
Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Globe Life Inc. (NYSE: GL); Paragon 28, Inc. (NYSE: FNA); Integra Lifesciences Holdings Corp. (NASDAQ: IART); Telephone and Data Systems, Inc. (NYSE: TDS); and Methode
February 06, 2025
From
Grabar Law Office
Via
GlobeNewswire
Notice To Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf
February 04, 2025
From
Grabar Law Office
Via
GlobeNewswire
Meet the Only 3 S&P 500 Stocks That Are Beating Nvidia This Year
↗
December 05, 2024
Via
The Motley Fool
Topics
Stocks
NASDAQ:IART is an undervalued gem with solid fundamentals.
↗
July 25, 2024
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is an undervalued gem with solid fundamentals.
Via
Chartmill
8 Analysts Have This To Say About Integra Lifesciences
↗
July 15, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts
↗
May 07, 2024
Via
Benzinga
Why Is Integra LifeSciences Stock Soaring On Monday?
↗
November 04, 2024
Integra LifeSciences' Q3 results show adjusted EPS of $0.41 and revenue at $380.83 million. Codman segment grows 1%, while Tissue Tech sees a 3.6% decline.
Via
Benzinga
Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday
↗
November 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 04, 2024
Via
Benzinga
Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm
September 19, 2024
From
KASKELA LAW LLC
Via
Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 3
↗
August 03, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of July 29 through Aug. 2.
Via
Talk Markets
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
July 29, 2024
Via
Benzinga
Why Integra Lifesciences Stock Is Sinking Today
↗
July 29, 2024
Q2 revenue and earnings beats didn't make up for the company's full-year guidance cut.
Via
The Motley Fool
Topics
Earnings
IART Stock Earnings: Integra Lifesciences Beats EPS, Beats Revenue for Q2 2024
↗
July 29, 2024
IART stock results show that Integra Lifesciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
July 29, 2024
Via
Benzinga
The 3 Best Brain-Computer Interface Stocks to Buy Now
↗
July 27, 2024
With the number of U.S. citizens aged 65 and above growing to 55.8 million, we could see brain-computer interface stocks accelerate.
Via
InvestorPlace
INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART
July 19, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
For those who appreciate value investing, NASDAQ:IART is a compelling option with its solid fundamentals.
↗
July 03, 2024
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART), an undervalued stock with good fundamentals.
Via
Chartmill
INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART
June 24, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
NASDAQ:IART appears to be flying under the radar despite its strong fundamentals.
↗
June 11, 2024
Despite its impressive fundamentals, INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) remains undervalued.
Via
Chartmill
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
↗
June 07, 2024
KKR and GoDaddy also will join before the open on June 24.
Via
Investor's Business Daily
Topics
Stocks
$1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
↗
May 28, 2024
Via
Benzinga
NASDAQ:IART is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
↗
May 08, 2024
Investors should take notice ofINTEGRA LIFESCIENCES HOLDING (NASDAQ:IART)—it offers a great deal for the fundamentals it presents.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
